HomeIMDX • NASDAQ
Insight Molecular Diagnostics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 518.00K | 398.08% |
Operating expense | 7.39M | 28.82% |
Net income | -9.74M | -115.06% |
Net profit margin | -1.88K | 56.82% |
Earnings per share | -0.30 | 30.56% |
EBITDA | -6.48M | -21.40% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 24.29M | 162.39% |
Total assets | 50.52M | -32.39% |
Total liabilities | 49.42M | -4.99% |
Total equity | 1.10M | — |
Shares outstanding | 28.62M | — |
Price to book | 64.00 | — |
Return on assets | -31.74% | — |
Return on capital | -193.69% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -9.74M | -115.06% |
Cash from operations | -6.28M | -5.04% |
Cash from investing | -349.00K | -82.72% |
Cash from financing | -114.00K | -101.16% |
Net change in cash | -6.74M | -283.31% |
Free cash flow | -4.19M | -1.77% |
Previous close
$2.56
Day range
$2.46 - $2.55
Year range
$1.92 - $4.75
Market cap
70.69M USD
Avg Volume
33.62K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2009
Headquarters
Website
Employees
48